Toyama, Japan

Masaru Tai


Average Co-Inventor Count = 9.0

ph-index = 3

Forward Citations = 31(Granted Patents)


Company Filing History:


Years Active: 1978-1992

Loading Chart...
11 patents (USPTO):Explore Patents

Title: Innovations of Masaru Tai in Cephalosporin Development

Introduction

Masaru Tai is a prominent inventor based in Toyama, Japan, known for his significant contributions to the field of pharmaceuticals, particularly in the development of novel cephalosporins. With a total of 11 patents to his name, Tai has made remarkable advancements in antibacterial agents that are both effective and safe for use.

Latest Patents

Among his latest patents, Tai has developed a series of novel cephalosporins that feature unique structural modifications. These compounds include a substituted or unsubstituted aryl, acylamino, aromatic heterocyclic, triazolyl, or tetrazolyl group attached to the exomethylene group at the 3-position of the cephem ring. The innovative design allows for a broad antibacterial spectrum, stability against beta-lactamase produced by bacteria, low toxicity, and excellent absorption when administered orally or parenterally. The specific configurations of these compounds are designed to enhance their therapeutic efficacy.

Career Highlights

Throughout his career, Masaru Tai has worked with notable companies such as Toyama Chemical Co., Ltd. and Handi-pac, Inc. His work has not only contributed to the advancement of pharmaceutical sciences but has also positioned him as a key figure in the development of effective antibacterial treatments.

Collaborations

Tai has collaborated with esteemed colleagues, including Isamu Saikawa and Hiroyuki Imaizumi, to further enhance the research and development of cephalosporins. Their combined expertise has led to significant breakthroughs in the field.

Conclusion

Masaru Tai's innovative work in the development of cephalosporins has made a lasting impact on the pharmaceutical industry. His contributions continue to pave the way for new treatments that address bacterial infections effectively and safely.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…